Royce & Associates’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Royce & Associates’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-55,502	Closed	-$690K	–	1158
2016 Q4	$690K	Sell	55,502 -213,850	-79%	-$2.58M	﹤0.01%	983
2016 Q3	$3.69M	Sell	269,352 -106,000	-28%	-$1.06M	0.02%	677
2016 Q2	$2.77M	Hold	375,352	–	–	0.02%	744
2016 Q1	$2.4M	Hold	375,352	–	–	0.02%	801
2015 Q4	$2.35M	Hold	375,352	–	–	0.01%	817
2015 Q3	$2.19M	Hold	375,352	–	–	0.01%	853
2015 Q2	$3.1M	Hold	375,352	–	–	0.01%	852
2015 Q1	$3.09M	Sell	375,352 -65,250	-15%	-$482K	0.01%	856
2014 Q4	$3.03M	Hold	440,602	–	–	0.01%	890
2014 Q3	$2.38M	Sell	440,602 -40,000	-8%	-$234K	0.01%	973
2014 Q2	$3.06M	Sell	480,602 -36,000	-7%	-$248K	0.01%	966
2014 Q1	$4.16M	Sell	516,602 -170,000	-25%	-$1.32M	0.01%	924
2013 Q4	$4.68M	Buy	+686,602	New	+$3.71M	0.01%	875

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return

Royce & Associates's ARIA Position: Q1 2017 in Review

Royce & Associates sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 55,502 shares — an estimated $690K sold.

Royce & Associates first reported a position in ARIA in Q4 2013 and held it in 13 quarters. The position peaked at $4.68M in Q4 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Royce & Associates reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Royce & Associates sold 55,502 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $690K.
Royce & Associates first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 13 quarters.
Royce & Associates's Ariad Pharmaceuticals Inc position peaked at $4.68M in Q4 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Royce & Associates's 13F filing for Q1 2017, filed 11 May 2017.